Clinical Study
Cysticerci Drive Dendritic Cells to Promote In Vitro and In Vivo Tregs Differentiation
Table 2
Phenotype of peripheral dendritic and regulatory T cells in NC patients and healthy subjects.
| Phenotype | NC patients | Healthy subjects | P |
| Dendritic cells | | | | SLAM+CD11C+ | 9.65 ± 5.66 | 3.80 ± 1.88 | 0.045 | CD205+CD11C+ | 21.55 ± 13.64 | 4.27 ± 3.12 | 0.014 | ILT3+CD11C+ | 35.01 ± 27.61 | 31.48 ± 28.70 | 0.813 | HLA-DR+CD11C+ | 71.47 ± 19.87 | 69.05 ± 12.96 | 0.805 | CD86+CD11C+ | 39.70 ± 25.87 | 54.21 ±12.45 | 0.250 | CD40+CD11C+ | 7.92 ± 7.98 | 2.81 ± 1.49 | 0.182 | T cells | | | | CD4+CD25 High FoxP3+CD127−/low | 14.22 ± 9.08 | 4.35 ± 4.26 | 0.0194 |
T lymphocytes | 30.85 ± 11.49 | 43.59 ± 5.60 | 0.07 |
|
|